Aug 9, 2023 • 12:30 PM EDT Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
Jul 10, 2023 • 3:59 PM EDT Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
Jun 5, 2023 • 4:05 PM EDT Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023